(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
Robert A. Breyer
Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee, Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Robert A. Breyer, also known as Bob served as the President of Alkermes Inc. from July 1994 to December 2001 and its Chief Operating Officer from July 1994 to February 2001. Mr. Breyer was a Part-Time Employee of Alkermes. From August 1991 to December 1993, he served as the President and General Manager of Eli Lilly Italy, a subsidiary of Eli Lilly and Company. From September 1987 to August 1991, he served as Senior Vice President of Marketing and Sales at IVAC Corporation, ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*
Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee
North Dakota State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|Thomas W. D'Alonzo Esq., J.D.||Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee|
Salix Pharmaceuticals Ltd.
|Arun Sawhney B.Com., P.G.D.B.M.||Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee|
Ranbaxy Laboratories Ltd.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|--||Compensation as of Fiscal Year 2013.|